TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL PERSONALIZED MEDICINE MARKET, BY PRODUCT
6.1. Overview
6.2. Personalized Medicine Diagnostics
6.3. Personalized Medicine Therapeutics
6.4. Personalized Medical Care
6.5. Personalized Nutrition and Wellness
7. GLOBAL PERSONALIZED MEDICINE MARKET, BY APPLICATION
7.1. Overview
7.2. Oncology
7.3. CNS
7.4. Immunology
7.5. Respiratory
7.6. Others
8. GLOBAL PERSONALIZED MEDICINE MARKET, BY END-USER
8.1. Overview
8.2. Hospitals
8.3. Diagnostic Centers
8.4. Research & Academic Institutes
8.5. Others
9. GLOBAL PERSONALIZED MEDICINE MARKET, BY REGION
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. South Korea
9.4.5. Australia
9.4.6. Rest of Asia-Pacific
9.5. Rest of the World
9.5.1. Middle East
9.5.2. Africa
9.5.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Personalized Medicine Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Personalized Medicine Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Application Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022
11. COMPANY PROFILES
11.1. Illumina Inc.
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Precision Biologics
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Danaher Corporation
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. GE Healthcare
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Celera Diagnostics LLC
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. DECODE GENETICS INC.
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Exact Sciences Corporation
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. IBM Corporation
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Exagen Inc.
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Biogen
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL PERSONALIZED MEDICINE MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL PERSONALIZED MEDICINE MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 9 NORTH AMERICA PERSONALIZED MEDICINE MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 10 U.S. PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 11 U.S. PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 12 U.S. PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 13 CANADA PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 14 CANADA PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 15 CANADA PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 16 EUROPE PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 17 EUROPE PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 18 EUROPE PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 19 EUROPE PERSONALIZED MEDICINE MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 20 GERMANY PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 21 GERMANY PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 22 GERMANY PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 23 FRANCE PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 24 FRANCE PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 25 FRANCE PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 26 ITALY PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 27 ITALY PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 28 ITALY PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 29 SPAIN PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 30 SPAIN PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 31 SPAIN PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 32 U.K PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 33 U.K PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 34 U.K PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 35 REST OF EUROPE PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 36 REST OF EUROPE PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 37 REST OF EUROPE PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 38 ASIA PACIFIC PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 39 ASIA PACIFIC PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 40 ASIA PACIFIC PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 41 ASIA PACIFIC PERSONALIZED MEDICINE MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 42 JAPAN PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 43 JAPAN PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 44 JAPAN PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 45 CHINA PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 46 CHINA PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 47 CHINA PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 48 INDIA PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 49 INDIA PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 50 INDIA PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 51 AUSTRALIA PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 52 AUSTRALIA PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 53 AUSTRALIA PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 54 SOUTH KOREA PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 55 SOUTH KOREA PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 56 SOUTH KOREA PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 57 REST OF ASIA-PACIFIC PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 58 REST OF ASIA-PACIFIC PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 59 REST OF ASIA-PACIFIC PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 60 REST OF WORLD PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 61 REST OF WORLD PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 62 REST OF WORLD PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 63 REST OF WORLD PERSONALIZED MEDICINE MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 64 MIDDLE EAST PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 65 MIDDLE EAST PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 66 MIDDLE EAST PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 67 AFRICA PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 68 AFRICA PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 69 AFRICA PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 70 LATIN AMERICA PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 71 LATIN AMERICA PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 72 LATIN AMERICA PERSONALIZED MEDICINE MARKET, BY END-USER, 2018-2032 (USD BILLION) 
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PERSONALIZED MEDICINE MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PERSONALIZED MEDICINE MARKET
FIGURE 4 GLOBAL PERSONALIZED MEDICINE MARKET, SHARE (%), BY PRODUCT, 2022
FIGURE 5 GLOBAL PERSONALIZED MEDICINE MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 6 GLOBAL PERSONALIZED MEDICINE MARKET, SHARE (%), BY END-USER, 2022
FIGURE 7 GLOBAL PERSONALIZED MEDICINE MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 NORTH AMERICA: PERSONALIZED MEDICINE MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 EUROPE: PERSONALIZED MEDICINE MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 ASIA-PACIFIC: PERSONALIZED MEDICINE MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 REST OF THE WORLD: PERSONALIZED MEDICINE MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 GLOBAL PERSONALIZED MEDICINE MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 13 ILLUMINA INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 ILLUMINA INC.: SWOT ANALYSIS
FIGURE 15 PRECISION BIOLOGICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 PRECISION BIOLOGICS: SWOT ANALYSIS
FIGURE 17 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 DANAHER CORPORATION: SWOT ANALYSIS
FIGURE 19 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 GE HEALTHCARE: SWOT ANALYSIS
FIGURE 21 CELERA DIAGNOSTICS LLC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 CELERA DIAGNOSTICS LLC.: SWOT ANALYSIS
FIGURE 23 DECODE GENETICS INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 DECODE GENETICS INC.: SWOT ANALYSIS
FIGURE 25 EXACT SCIENCES CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 EXACT SCIENCES CORPORATION: SWOT ANALYSIS
FIGURE 27 IBM CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 IBM CORPORATION: SWOT ANALYSIS
FIGURE 29 EXAGEN INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 EXAGEN INC.: SWOT ANALYSIS
FIGURE 31 BIOGEN: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 BIOGEN: SWOT ANALYSIS
